Del Tacca M - Search Results

1

Time-dependent pharmacokinetics of 5-fluorouracil and association with treatment tolerability in the adjuvant setting of colorectal cancer.

Ibrahim T, Di Paolo A, Amatori F, Mercatali L, Ravaioli E, Flamini E, Sacanna E, Del Tacca M, Danesi R, Amadori D. Ibrahim T, et al. Among authors: del tacca m. J Clin Pharmacol. 2012 Mar;52(3):361-9. doi: 10.1177/0091270010396710. Epub 2011 Mar 7. J Clin Pharmacol. 2012. PMID: 21383342 Clinical Trial.

2

Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancer.

Di Paolo A, Danesi R, Vannozzi F, Falcone A, Mini E, Cionini L, Ibrahim T, Amadori D, Del Tacca M. Di Paolo A, et al. Among authors: del tacca m. Clin Pharmacol Ther. 2002 Dec;72(6):627-37. doi: 10.1067/mcp.2002.128867. Clin Pharmacol Ther. 2002. PMID: 12496744

3

5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer.

Di Paolo A, Lencioni M, Amatori F, Di Donato S, Bocci G, Orlandini C, Lastella M, Federici F, Iannopollo M, Falcone A, Ricci S, Del Tacca M, Danesi R. Di Paolo A, et al. Among authors: del tacca m. Clin Cancer Res. 2008 May 1;14(9):2749-55. doi: 10.1158/1078-0432.CCR-07-1529. Clin Cancer Res. 2008. PMID: 18451241 Free article.

4

Clinical pharmacokinetics of irinotecan-based chemotherapy in colorectal cancer patients.

Di Paolo A, Bocci G, Danesi R, Del Tacca M. Di Paolo A, et al. Among authors: del tacca m. Curr Clin Pharmacol. 2006 Sep;1(3):311-23. doi: 10.2174/157488406778249307. Curr Clin Pharmacol. 2006. PMID: 18666754 Review.

5

Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role.

Blandizzi C, Danesi R, De Paolis B, Di Paolo A, Colucci R, Falcone A, Del Tacca M. Blandizzi C, et al. Among authors: del tacca m. Clin Pharmacol Ther. 2002 Apr;71(4):263-71. doi: 10.1067/mcp.2002.121909. Clin Pharmacol Ther. 2002. PMID: 11956509

6

Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients.

Danesi R, Innocenti F, Fogli S, Gennari A, Baldini E, Di Paolo A, Salvadori B, Bocci G, Conte PF, Del Tacca M. Danesi R, et al. Among authors: del tacca m. Br J Clin Pharmacol. 2002 May;53(5):508-18. doi: 10.1046/j.1365-2125.2002.01579.x. Br J Clin Pharmacol. 2002. PMID: 11994057 Free PMC article. Clinical Trial.

7

Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer.

Falcone A, Masi G, Allegrini G, Danesi R, Pfanner E, Brunetti IM, Di Paolo A, Cupini S, Del Tacca M, Conte P. Falcone A, et al. Among authors: del tacca m. J Clin Oncol. 2002 Oct 1;20(19):4006-14. doi: 10.1200/JCO.2002.12.075. J Clin Oncol. 2002. PMID: 12351598 Clinical Trial.

8

Relationship between plasma concentrations of 5-fluorouracil and 5-fluoro-5,6-dihydrouracil and toxicity of 5-fluorouracil infusions in cancer patients.

Di Paolo A, Ibrahim T, Danesi R, Maltoni M, Vannozzi F, Flamini E, Zoli W, Amadori D, Del Tacca M. Di Paolo A, et al. Among authors: del tacca m. Ther Drug Monit. 2002 Oct;24(5):588-93. doi: 10.1097/00007691-200210000-00002. Ther Drug Monit. 2002. PMID: 12352929

9

A phase I and pharmacokinetic study of irinotecan given as a 7-day continuous infusion in metastatic colorectal cancer patients pretreated with 5-fluorouracil or raltitrexed.

Masi G, Falcone A, Di Paolo A, Allegrini G, Danesi R, Barbara C, Cupini S, Del Tacca M. Masi G, et al. Among authors: del tacca m. Clin Cancer Res. 2004 Mar 1;10(5):1657-63. doi: 10.1158/1078-0432.ccr-1585-3. Clin Cancer Res. 2004. PMID: 15014016 Clinical Trial.

10

Improved analysis of 5-Fluorouracil and 5,6-dihydro-5-Fluorouracil by HPLC with diode array detection for determination of cellular dihydropyrimidine dehydrogenase activity and pharmacokinetic profiling.

Di Paolo A, Danesi R, Ciofi L, Vannozzi F, Bocci G, Lastella M, Amatori F, Martelloni BM, Ibrahim T, Amadori D, Falcone A, Del Tacca M. Di Paolo A, et al. Among authors: del tacca m. Ther Drug Monit. 2005 Jun;27(3):362-8. doi: 10.1097/01.ftd.0000162016.11148.1b. Ther Drug Monit. 2005. PMID: 15905808

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

339 results

Search Page